Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden

Vaccine effectiveness against COVID-19 beyond 6 months remains incompletely understood. We aimed to investigate the effectiveness of COVID-19 vaccination against the risk of infection, hospitalisation, and death during the first 9 months after vaccination for the total population of Sweden. This ret...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 399; no. 10327; pp. 814 - 823
Main Authors:	Nordström, Peter, Ballin, Marcel, Nordström, Anna
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 26.02.2022 Elsevier Limited
Subjects:	2019-nCoV Vaccine mRNA-1273 - administration & dosage 2019-nCoV Vaccine mRNA-1273 - immunology BNT162 Vaccine - administration & dosage BNT162 Vaccine - immunology ChAdOx1 nCoV-19 - administration & dosage ChAdOx1 nCoV-19 - immunology Clinical trials Cohort analysis Coronaviruses COVID-19 COVID-19 - mortality COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - administration & dosage COVID-19 Vaccines - immunology Drug dosages Female Health risks Homology Hospitalization Hospitalization - statistics & numerical data Humans Infections Male Middle Aged Mortality mRNA Older people Population Population studies Population-based studies Retrospective Studies Severe acute respiratory syndrome coronavirus 2 Severity of Illness Index Subgroups Sweden Time Factors Vaccination Vaccination - statistics & numerical data Vaccine efficacy Vaccines Sweden Brazil Scotland United Kingdom > UK United States > US Qatar
ISSN:	0140-6736, 1474-547X, 1474-547X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!